search
Back to results

Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis (CBTd-E)

Primary Purpose

Schizophrenia, Psychotic Disorders, Delusions

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
emotion-oriented Cognitive Behavior Therapy
Sponsored by
Philipps University Marburg Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Schizophrenia focused on measuring Delusions, Schizophrenia, Cognitive Behavior Therapy, Emotion, Emotion regulation, self-esteem, sleep quality, Efficacy of change

Eligibility Criteria

16 Years - 70 Years (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Treatment Group:

Inclusion Criteria:

  • Diagnosis of schizophrenia, schizoaffective disorder, delusional disorder (DSM-5 diagnosis)
  • Delusions present in the last three months (score of at least three in three out of six PSYRATS scores)
  • problems in at least two out of three possible mediators: sleep problems (ISI sum score > 7), low self-esteem (score > 3in the BCSS negative self scale) and/or problems in emotion regulation (score in all items < 4)
  • fluent in German language
  • agree to participate
  • estimated general intelligence of at least 70 in the German Mehrfachwahlwortschatztest (MWT-B)
  • no present suicidality

Exclusion Criteria:

  • acute suicidal tendency
  • comorbid diagnosis of borderline personality disorder and/or substance use disorder in the last six month
  • taking of Benzodiazepines

Sites / Locations

  • University of Marburg, Faculty of Clinical Psychology and Psychotherapy
  • University of Hamburg, Faculty of Clinical Psychology and Psychotherapy

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

CBTd-E

Treatment as Usual

Arm Description

Experimental: emotion-oriented Cognitive Behavior Therapy focused on delusions for patients with schizophrenia-spectrum disorders and delusions. The therapeutical intervention follows a treatment-manual consisting of two modules. Patients work on two modules every week for 25 weeks in a row. Module I comprises psychoeducation on emotions, training radical acceptance of emotions and mindfulness, cognitive and behavioral strategies in order to change negative emotions and in order to foster positive emotions and suggestions for life-style changes (positive activities, sports, stress reduction). In the second module, the focus is on self-acceptance. Patients receive psychoeducation on self-acceptance and learn strategies in order to reduce negative self-schema and foster positive self-schema.

Patients who are randomized and assigned to the Wait-list receive treatment as usual (regular visits to a physicist every third month and antipsychotic medication). After six month the waiting list patients receive the treatment specified above.

Outcomes

Primary Outcome Measures

Change in Psychotic Rating Scale (PSYRATS) delusions scale
Assessment of delusion frequency, delusion distress, conviction and loss of quality of life due to the delusion

Secondary Outcome Measures

Change in Positive and Negative Syndrome Scale (PANSS)
Assessment of positive, negative and general symptoms of schizophrenia
Change in Calgary Depression Rating Scale for Schizophrenia (CDSS(
Assessment of depressive symptoms in patients with schizophrenia
Change in Role Functioning Scale (RFS)
Assessment of social functioning
Change in Peters et al. Delusions Inventory (PDI- R)
Assessment of self-rated delusion frequency, conviction and distress.

Full Information

First Posted
February 26, 2016
Last Updated
March 3, 2020
Sponsor
Philipps University Marburg Medical Center
Collaborators
University of Hamburg-Eppendorf, Ruhr University of Bochum
search

1. Study Identification

Unique Protocol Identification Number
NCT02787135
Brief Title
Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis
Acronym
CBTd-E
Official Title
Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis (CBTp-E) in Reducing Delusions. A Randomized-controlled Treatment Study (CBTd-E)
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
May 1, 2016 (Actual)
Primary Completion Date
December 31, 2019 (Actual)
Study Completion Date
December 31, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Philipps University Marburg Medical Center
Collaborators
University of Hamburg-Eppendorf, Ruhr University of Bochum

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of the present single-blind randomized-controlled therapy study is to assess the efficacy of a new form of Cognitive Behavioral Therapy for delusions with a focus on emotion regulation, improvement of self-esteem and sleep quality (CBTd-E).
Detailed Description
Numerous meta-analyses have found Cognitive Behaviour Therapy for psychosis (CBTp) to be effective. The effect sizes that are achieved for positive symptoms in addition to antipsychotic treatment vary between small to medium. However, the effect sizes for changes in delusions are somewhat lower. Thus, it could prove beneficial to tailor CBTp interventions more precisely to the processes that are relevant to delusions. Empirically derived models of the formation and maintenance of delusions postulate an important role of cognitive biases, emotional factors and self-esteem. Additional studies have demonstrated the relevance of impaired sleep to delusions. Nevertheless, CBTp interventions that aim to change delusions tend to focus mainly on reasoning bias. The results of several uncontrolled pilot studies that focused primarily at improving emotional factors, quality of sleep and self-esteem in patients with delusions indicate that changes in these factors have the potential to reduce delusions. However, in these studies the singular interventions were short and were not implemented into a broader therapy rational. It can thus be assumed that a combination of CBT-interventions within a broader therapy rational might have an even greater impact on delusions. The aim of the present single-blind randomized-controlled therapy study is to assess the efficacy of a new form of Cognitive Behavioral Therapy for delusions with a focus on emotion regulation, improvement of self-esteem and sleep quality (CBTd-E) that will be applied in 25 individual sessions. Moreover, the study aims to test whether the efficacy of CBTd-E is mediated by the postulated processes. The main hypotheses are: Baseline differences: in comparison to healthy controls, patients with schizophrenia show more pronounced problems in emotion regulation, a reduced sleep quality and a lower and less stable self-esteem. Efficacy of CBTd-E: patients with acute delusions who receive CBTd-E show a more pronounced reduction of delusions (primary outcome), as well as a more pronounced reduction of positive symptoms, depression and general psychopathology, a stronger improvement in general and social functioning and will receive lower doses of antipsychotic medication (secondary outcomes) at post-treatment. Mediation: the effect of CBTd-E on change in delusions is mediated by a) improved emotional stability and ability to regulate one's own emotions, b) improved sleep quality, c) improved and more stable self-esteem. In addition to questionnaires and interviews, behavioral paradigms, psychophysiological assessments and electronic diaries will be used to test the hypotheses. If we can demonstrate that CBTd-E reduces delusions, this would provide us with a more acceptable and feasible therapy for treating delusions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia, Psychotic Disorders, Delusions, Emotions, Self-esteem, Sleep
Keywords
Delusions, Schizophrenia, Cognitive Behavior Therapy, Emotion, Emotion regulation, self-esteem, sleep quality, Efficacy of change

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
94 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CBTd-E
Arm Type
Active Comparator
Arm Description
Experimental: emotion-oriented Cognitive Behavior Therapy focused on delusions for patients with schizophrenia-spectrum disorders and delusions. The therapeutical intervention follows a treatment-manual consisting of two modules. Patients work on two modules every week for 25 weeks in a row. Module I comprises psychoeducation on emotions, training radical acceptance of emotions and mindfulness, cognitive and behavioral strategies in order to change negative emotions and in order to foster positive emotions and suggestions for life-style changes (positive activities, sports, stress reduction). In the second module, the focus is on self-acceptance. Patients receive psychoeducation on self-acceptance and learn strategies in order to reduce negative self-schema and foster positive self-schema.
Arm Title
Treatment as Usual
Arm Type
Placebo Comparator
Arm Description
Patients who are randomized and assigned to the Wait-list receive treatment as usual (regular visits to a physicist every third month and antipsychotic medication). After six month the waiting list patients receive the treatment specified above.
Intervention Type
Behavioral
Intervention Name(s)
emotion-oriented Cognitive Behavior Therapy
Other Intervention Name(s)
CBTd-E
Intervention Description
Emotion-oriented Cognitive Behavior Therapy with a focus on delusions: Aim of the intervention is to change factors that are involved in the formation and maintenance of delusions: emotional stability and regulation of negative emotions, sleep quality and self-esteem.
Primary Outcome Measure Information:
Title
Change in Psychotic Rating Scale (PSYRATS) delusions scale
Description
Assessment of delusion frequency, delusion distress, conviction and loss of quality of life due to the delusion
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Secondary Outcome Measure Information:
Title
Change in Positive and Negative Syndrome Scale (PANSS)
Description
Assessment of positive, negative and general symptoms of schizophrenia
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in Calgary Depression Rating Scale for Schizophrenia (CDSS(
Description
Assessment of depressive symptoms in patients with schizophrenia
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in Role Functioning Scale (RFS)
Description
Assessment of social functioning
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in Peters et al. Delusions Inventory (PDI- R)
Description
Assessment of self-rated delusion frequency, conviction and distress.
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Other Pre-specified Outcome Measures:
Title
Change in Emotion-regulation Questionnaire (ERQ)
Description
Questionnaire assesses the regular use of emotion regulation strategies
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in Emotion regulation inventory
Description
Questionnaire assesses the regular use of emotion regulation strategies
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in Paranoia assessed with Electronical mobile assessment
Description
Assessment of present emotions, emotion regulation strategies, present symptoms of psychosis, present delusions, self-esteem for six consecutive days (10 assessments per day) in daily life
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in Sleep quality as assessed with an Actiwatch
Description
Assessment of sleep-quality using an electronic bracelet for six consecutive days, sleep quality is assessed with movement detectors and light sensors
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in Emotion regulation quality as assessed experimental using International Affect Picture System Paradigm for the Assessment of emotion regulation (IAPS)
Description
Assessment of effectiveness of use of emotion regulation strategies after experimental induction of fear, assessment of heart rate and skin conduction
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in heart rate variability
Description
Assessment of heart rate variability with sensors during stress induction (reaction experiment) and during rest
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in Brief Core Schema Scale (BCSS)
Description
Assessment of positive and negative self-schemata and schemata on others
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in Insomnia Severity Index (ISI)
Description
The ISI assesses present sleep problems
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in Self-Compassion Scale (SCS)
Description
SCS assesses self-compassion and self-esteem
Time Frame
Change between pre-therapy and post-therapy assessment after six month
Title
Change in Self-perception of emotional competencies (SEK-27)
Description
Questionnaire assesses the regular use of emotion regulation strategies
Time Frame
Change between pre-therapy and post-therapy assessment after six month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Treatment Group: Inclusion Criteria: Diagnosis of schizophrenia, schizoaffective disorder, delusional disorder (DSM-5 diagnosis) Delusions present in the last three months (score of at least three in three out of six PSYRATS scores) problems in at least two out of three possible mediators: sleep problems (ISI sum score > 7), low self-esteem (score > 3in the BCSS negative self scale) and/or problems in emotion regulation (score in all items < 4) fluent in German language agree to participate estimated general intelligence of at least 70 in the German Mehrfachwahlwortschatztest (MWT-B) no present suicidality Exclusion Criteria: acute suicidal tendency comorbid diagnosis of borderline personality disorder and/or substance use disorder in the last six month taking of Benzodiazepines
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stephanie Mehl, Ph. D.
Organizational Affiliation
Philipps University Marburg Medical Center
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Tania M Lincoln, Ph. D.
Organizational Affiliation
University of Hamburg-Eppendorf
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Tobias Teismann, Ph. D.
Organizational Affiliation
Ruhr University of Bochum
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Marburg, Faculty of Clinical Psychology and Psychotherapy
City
Marburg
State/Province
Hessen
ZIP/Postal Code
35037
Country
Germany
Facility Name
University of Hamburg, Faculty of Clinical Psychology and Psychotherapy
City
Hamburg
ZIP/Postal Code
20146
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33211503
Citation
Kammerer MK, Mehl S, Ludwig L, Lincoln TM. Sleep and circadian rhythm disruption predict persecutory symptom severity in day-to-day life: A combined actigraphy and experience sampling study. J Abnorm Psychol. 2021 Jan;130(1):78-88. doi: 10.1037/abn0000645. Epub 2020 Nov 19.
Results Reference
derived
PubMed Identifier
32105124
Citation
Ludwig L, Mehl S, Krkovic K, Lincoln TM. Effectiveness of emotion regulation in daily life in individuals with psychosis and nonclinical controls-An experience-sampling study. J Abnorm Psychol. 2020 May;129(4):408-421. doi: 10.1037/abn0000505. Epub 2020 Feb 27.
Results Reference
derived

Learn more about this trial

Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis

We'll reach out to this number within 24 hrs